Closure Device News Today : Breaking News, Live Updates & Top Stories | Vimarsana

GALWAY, Ireland, November 14, 2023--Vivasure Medical®, a company pioneering novel fully absorbable technology for percutaneous vessel closure, today announced it has enrolled the 100th patient in its PATCH Clinical Study, a multi-center, single-arm, pivotal study evaluating the safety and efficacy of the Vivasure PerQseal® Closure Device System. The U.S. Food and Drug Administration (FDA) granted investigational device exemption (IDE) approval earlier this year to advance the PATCH study forward

The global vascular closure device market is growing at a CAGR of 7.1% from 2022 to 2030.Pune, India, Nov. 08, 2023 (GLOBE NEWSWIRE) -- A vascular closure device is a piece of collagen (a fibrous protein found in skin, connective tissue, and bone), a metallic clip, or a suture designed to close the small puncture produced in an artery following an angiography. According to our new research study on “Vascular Closure Device Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trend

Dublin, April 27, 2023 (GLOBE NEWSWIRE) -- The "Femoral Closure Devices: Market Snapshot" report has been added to ResearchAndMarkets.com's offering. ...

Dublin, Dec. 05, 2022 (GLOBE NEWSWIRE) -- The "Sternal Closure Systems Market by Product (Closure Devices (Wires, Plate & Screw, Cable, Clips) Bone...

Left atrial appendage closure, also called LAA closure or LAAC, is a minimally invasive medical procedure used to drastically reduce the risk of stroke in...